Thus, it seems plausible that the ability of allopregnanolone to inhibit both TLR4 and TLR7 interactions with MyD88 and their pathways contribute to its therapeutic actions in the treatment of post-partum depression (43) and post-traumatic stress disorders (106) and may have beneficial actions in other inflammatory conditions. The gene discussed is TLR4; the disease is postpartum depression.